Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout
Open Access
- 1 August 2007
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 66 (8) , 1056-1058
- https://doi.org/10.1136/ard.2006.060368
Abstract
Objectives: To determine whether hypouricaemic treatment results in the disappearance of urate crystals from gouty joints and to define the time required. Methods: In 18 patients with monosodium urate (MSU) crystal proven gout, and after the initiation of successful serum uric acid (SUA)-lowering treatment, an arthrocentesis of the asymptomatic signal joint (11 knees, 7 first metatarsophalangeal joints) was performed every 3 months to obtain a synovial fluid (SF) sample. The sample was then analysed for the presence of MSU crystals, and the number of crystals/400× field was noted. SUA levels and the duration of gout were also noted. Results: MSU crystals disappeared from the SF of all 18 joints after reduction of SUA to normal levels. The time required for disappearance ranged from 3 to 33 months; disappearance time correlated with the duration of gout (rs = 0.71; pConclusions: In gout, reduction of SUA to normal levels results in disappearance of urate crystals from SF, requiring a longer time in those patients with gout of longer duration. This indicates that urate crystal deposition in joints is reversible. Normalisation of SUA levels results in a decrease in the concentration of MSU crystals in SF in the asymptomatic gouty joints. This may partially explain the reduced frequency of gouty attacks when a patient has been treated with SUA-lowering drugs.Keywords
This publication has 16 references indexed in Scilit:
- Synovial fluid analysisBest Practice & Research Clinical Rheumatology, 2005
- Analysis for crystals in synovial fluid: training of the analysts results in high consistencyAnnals of the Rheumatic Diseases, 2005
- Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims.2004
- A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: Evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapyArthritis Care & Research, 2004
- Effect of urate‐lowering therapy on the velocity of size reduction of tophi in chronic goutArthritis Care & Research, 2002
- A QUANTITATIVE STUDY OF THE PHAGOCYTOSIS OF URATE CRYSTALS IN THE SYNOVIAL FLUID OF ASYMPTOMATIC JOINTS OF PATIENTS WITH GOUTRheumatology, 1995
- Persistence of monosodium urate crystals and low‐grade inflammation in the synovial fluid of patients with untreated goutArthritis & Rheumatism, 1991
- Withdrawal of allopurinol in patients with gout.Annals of the Rheumatic Diseases, 1974
- PRINCIPLES OF CURRENT MANAGEMENT OF PRIMARY GOUTThe Lancet Healthy Longevity, 1967
- Mobilization of gouty tophi by protracted use of uricosuric agentsThe American Journal of Medicine, 1951